Prosecution Insights
Last updated: November 20, 2026
Application No. 19/196,000

SYSTEMS AND METHODS FOR DETERMINING UNTREATED HEALTH-RELATED ISSUES

Non-Final OA §101§103§112
Filed
May 01, 2025
Priority
Dec 15, 2020 — provisional 63/125,663 +3 more
Examiner
HODGE, LAURA NICOLE
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
RESMED Pty Ltd.
OA Round
1 (Non-Final)
49%
Grant Probability
Moderate
1-2
OA Rounds
2y 0m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
62 granted / 126 resolved
-20.8% vs TC avg
Strong +40% interview lift
Without
With
+40.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
54 currently pending
Career history
189
Total Applications
across all art units

Statute-Specific Performance

§101
26.0%
-14.0% vs TC avg
§103
34.4%
-5.6% vs TC avg
§102
8.7%
-31.3% vs TC avg
§112
25.3%
-14.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 126 resolved cases

Office Action

§101 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement (IDS) submitted on 4/2/26 and 5/5/26 are being considered by the examiner. Claim Objections Claim 1 is objected to because of the following informalities: the limitation “wherein at least some of the (i) the first physiological data, (ii) the second physiological data, or (iii) both the first physiological data and the second physiological data” should recite --wherein at least (i) the first physiological data, (ii) the second physiological data, or (iii) both the first physiological data and the second physiological data-- for clarity purposes. Appropriate correction is required. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: a mobile device in claim 1. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. For “a mobile device” in claim 1, the specification discloses “the mobile device 170 can be, for example, a mobile device such as a smart phone, a tablet, a gaming console, a smart watch, a laptop, or the like” (¶100). Therefore, the Examiner is interpreting the mobile device to be a smart phone, a tablet, a gaming console, a smart watch, a laptop, or equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 43-44 and 46 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 43-44 and 46 seem unclear. MPEP 2173.05(p): A single claim which claims both an apparatus and the method steps of using the apparatus is indefinite under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, second paragraph. See In re Katz Interactive Call Processing Patent Litigation, 639 F.3d 1303, 1318, 97 USPQ2d 1737, 1748-49 (Fed. Cir. 2011). It is unclear "whether infringement … occurs when one creates a system that allows the user [to use the input means], or whether infringement occurs when the user actually uses the input means."). Claims 43 and 44 recite both a system and a method. Claim 46 recites both a non-transitory computer readable medium and a method. In claim 44, the limitation of “an untreated sleep disorder” seems unclear. Claim 43 depends from claim 1 which recites “an untreated sleep disorder” in lines 1-2. It remains unclear how the limitation in claim 44 is different than the limitation in claim 1. For the purpose of examination, the Examiner is interpreted “an untreated sleep disorder” to be the same as the untreated sleep disorder in claim 1. The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 26 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 1 recites “receiving positional data associated with the user” and claim 26 which depends from claim 1 recites “wherein the sensor data includes positional data associated with the user.” Therefore, claim 26 does not further narrow claim 1 which it depends from. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-12, 16-20, 22-31, 43-44, and 46 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception, specifically an abstract idea. Step 1 The claimed invention in claims 1-12, 16-20, 22-31, 43-44, and 46 are directed to statutory subject matter as the claims recite a method, a system, and a non-transitory computer readable medium for determining a percentage likelihood that a user has an untreated sleep disorder. Step 2A, Prong One Regarding claim 1, the recited steps are directed to certain methods of organizing human activity and a mental process of performing concepts in a human mind or by a human using a pen and paper (see MPEP 2106.04(a)(2) subsections (II) and (III)). Regarding claim 1, the limitations of “receiving first physiological data associated with the user during a first time period; analyzing the first physiological data to determine (i) a first respiration rate for the first time period, (ii) a first plurality of sample heart rate values, and (iii) first heart rate variability parameters for the first time period; receiving second physiological data associated with the user during a second time period; analyzing the second physiological data to determine (i) a second respiration rate for the second time period, (ii) a second plurality of sample heart rate values, and (iii) second heart rate variability parameters for the second time period, the second respiration rate being less than the first respiration rate; determining the percentage likelihood that the user has the untreated sleep disorder based at least in part on the first heart rate variability parameters and the second heart rate variability parameters; receiving positional data associated with the user; and analyzing the received positional data to determine a body position of the user” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, these limitations are nothing more than a medical professional receiving a print out of first and second physiological data, analyzing the data to determine a respiration rate, a plurality of sample heart rates, and heart rate variability parameters, determining the percentage likelihood that the user has the untreated sleep disorder based at least in part on the first heart rate variability parameters and the second heart rate variability parameters, receiving a print out of positional data associated with the user, and analyzing the positional data to determine a body position of the user. Regarding claim 1, the limitation of “based, at least in part, on the determined body position of the user and the determined percentage likelihood that the user has the untreated sleep disorder, causing the user to change the body position” is a process, as drafted, covers performance of the limitation that are directed to organizing human activity (managing personal behavior or relationships or interactions between people including social activities, teaching, and following rules or instructions). For example, these limitations are nothing more than a medical professional based, at least in part, on the determined body position of the user and the determined percentage likelihood that the user has the untreated sleep disorder, instructing or waking the user to change the body position. Step 2A, Prong Two For claim 1, the judicial exception is not integrated into a practical application. In particular, claim 1 recites “a heart rate sensor, a pulse sensor, an accelerometer, a pulse oximeter, an ECG device, or any combination thereof of the mobile device.” The heart rate sensor, pulse sensor, accelerometer, pulse oximeter, ECG device, or any combination thereof of the mobile device amount to nothing more than pre-solution activity of data gathering. Merely including instructions to implement an abstract idea on a computer does not integrate a judicial exception into practical application. Step 2B The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional element of a heart rate sensor, a pulse sensor, an accelerometer, a pulse oximeter, an ECG device, or any combination thereof of the mobile device amounts to nothing more than mere pre-solution activity of data gathering, which does not amount to an inventive concept. Moreover, a heart rate sensor, a pulse sensor, an accelerometer, a pulse oximeter, an ECG device, or any combination thereof of the mobile device are recited at a high level of generality and are well-understood, routine, and conventional structures as evidenced by US 20050027203 (¶56-a conventional portable electrocardiograph), US 20140047259 (Abstract-accelerometer in the portable device), US 20200337583 (¶27-conventional portable ECG systems), and US 20220015709 (¶3-it is known that both the smart band and the fingertip pulse oximeter are portable). Further, simply appending well-understood, routine, conventional activities previously known to the industry, specified at a high level of generality, to the judicial exception, e.g., a claim to an abstract idea requiring no more than a generic computer to perform generic computer functions that are well-understood, routine and conventional activities previously known to the industry, as discussed in Alice Corp., 573 U.S. at 225, 110 USPQ2d at 1984 (see MPEP § 2106.05(d)). Regarding dependent claims 2-12, 16-20, 22-31, 43-44, and 46, the limitations of claim 1 further define the limitations already indicated as being directed to the abstract idea. Claims 2, 8, 18, 12, and 31 are further directed to the abstract idea indicated in claim 1 above. Regarding claims 3-4, the limitations of “wherein the first heart rate variability parameters for the first time period include a maximum heart rate for the first time period, a minimum heart rate for the first time period, a heart rate range defined by the maximum heart rate and the minimum heart rate for the first time period, an average heart rate for the first time period, a median heart rate for the first time period, a standard deviation of heart rates for the first time period, or any combination thereof” and “wherein the second heart rate variability parameters for the second time period include a maximum heart rate for the second time period, a minimum heart rate for the second time period, a heart rate range defined by the maximum heart rate and the minimum heart rate for the second time period, an average heart rate for the second time period, a median heart rate for the second time period, a standard deviation of heart rates for the second time period, or any combination thereof” are mathematical calculations of performing addition, subtraction, division, exponentials, and square roots in order to determine a percentage likelihood that a user has an untreated sleep disorder. Regarding claim 5, the limitations of “in response to the heart rate range for the second time period being no greater than the heart rate range for the first time period, determining that the percentage likelihood that the user has the untreated sleep disorder is greater than 40%, 50%, 60%, 70%, 80%, or 90%” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, these limitations are nothing more than a medical professional determining the second time period is no greater than the heart rate range for the first time period and determining that the percentage likelihood that the user has the untreated sleep disorder is greater than 40%, 50%, 60%, 70%, 80%, or 90%. Regarding claim 6, the limitations of “based at least in part on the heart rate range for the second time period not exceeding a threshold value, determining that the user is likely to have the untreated sleep disorder” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, these limitations are nothing more than a medical professional determining the heart rate range for the second time period does not exceed a threshold value and determining that the user is likely to have the untreated sleep disorder. Claim 7 is further directed to the abstract idea indicated in claim 6 above. Regarding claim 9, the limitations of “receiving a first time stamp associated with the first time period and a second time stamp associated with the second time period; and based at least in part on the first time stamp and the second time stamp, determining the percentage likelihood that the user has the untreated sleep disorder” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, these limitations are nothing more than a medical professional receiving a print out of a first time stamp associated with the first time period and a second time stamp associated with the second time period; and based at least in part on the first time stamp and the second time stamp, determining the percentage likelihood that the user has the untreated sleep disorder. Regarding claim 10, the limitations of “receiving a first time stamp associated with the first time period and a second time stamp associated with the second time period; and based at least in part on the first time stamp and the second time stamp, determining a severity of the untreated sleep disorder” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, these limitations are nothing more than a medical professional receiving a print out of a first time stamp associated with the first time period and a second time stamp associated with the second time period; and based at least in part on the first time stamp and the second time stamp, determining a severity of the untreated sleep disorder. Regarding claim 11, the limitations of “receiving additional physiological data associated with the user during an additional time period; analyzing the additional physiological data to determine (i) an additional respiration rate for the additional time period, (ii) an additional plurality of sample heart rate values, and (iii) additional heart rate variability parameters for the additional time period, the additional respiration rate being less than the first respiration rate; and determining a severity of the untreated sleep disorder based at least in part on the first heart rate variability parameters, the second heart rate variability parameters, and the additional heart rate variability parameters” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, these limitations are nothing more than a medical professional receiving a print out of additional physiological data associated with the user during an additional time period, analyzing the additional physiological data to determine (i) an additional respiration rate for the additional time period, (ii) an additional plurality of sample heart rate values, and (iii) additional heart rate variability parameters for the additional time period, the additional respiration rate being less than the first respiration rate, and determining a severity of the untreated sleep disorder based at least in part on the first heart rate variability parameters, the second heart rate variability parameters, and the additional heart rate variability parameters. Claim 16 is directed to post-solution activity of displaying an indication of the determined percentage likelihood that the user has the untreated sleep disorder. Regarding claim 17, the limitation of “in response to the determined percentage likelihood that the user has the untreated sleep disorder exceeding 50%” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, this limitation is nothing more than a medical professional determining the percentage likelihood that the user has the untreated sleep disorder exceeds 50%. Displaying an indication of the determined percentage likelihood that the user is likely to have the untreated sleep disorder is post-solution activity. Regarding claims 19-20, the limitations of “prior to receiving the second physiological data associated with the user during the second time period, causing the user to breathe slower than the first respiration rate” and “wherein the causing the user to breathe slower than the first respiration rate includes instructing the user to stay still and relax” are a process, as drafted, covers performance of the limitation that are directed to organizing human activity (managing personal behavior or relationships or interactions between people including social activities, teaching, and following rules or instructions). For example, these limitations are nothing more than a medical professional instructing the user to stay still and relax. Regarding claims 22-23, the limitations of “wherein the causing the user to change the body position includes causing a sound or a vibration to be communicated to the user” and “wherein a level of the sound or the vibration to be communicated to the user is (i) proportional to a determined severity of the untreated sleep disorder” are a process, as drafted, covers performance of the limitation that are directed to organizing human activity (managing personal behavior or relationships or interactions between people including social activities, teaching, and following rules or instructions). For example, these limitations are nothing more than a medical professional instructing the user to change the body position, wherein the sound communicated to the user is (i) proportional to a determined severity of the untreated sleep disorder. Regarding claim 24, the limitation of “based at least in part on the determined percentage likelihood that the user has the untreated sleep disorder, instructing the user to wear a treatment device” are a process, as drafted, covers performance of the limitation that are directed to organizing human activity (managing personal behavior or relationships or interactions between people including social activities, teaching, and following rules or instructions). For example, these limitations are nothing more than a medical professional instructing the user to wear a treatment device based at least in part on the determined percentage likelihood that the user has the untreated sleep disorder. Regarding claim 25, the limitation of “(i) generate sensor data” amounts to pre-solution activity of data gathering and the limitation of “ii) cause a sound or a vibration to be communicated to the user” amounts to post-solution activity. Claim 26 is further directed to pre-solution activity of data gathering. Regarding claims 27-28, wherein the motion sensor includes an accelerometer, a gyroscope, a magnetometer, or any combination thereof amounts to pre-solution activity of data gathering. An accelerometer, a gyroscope, a magnetometer, or any combination thereof amounts to a well-understood, routine, and conventional structure as evidenced by US 20100149541 (¶4-conventional accelerometers), US 20130305823 (¶4-conventional gyroscopes), and US 20050156601 (¶6-conventional induction magnetometers). Regarding claim 29, the limitations of “analyzing the generated sensor data to determine (i) a sleep disorder event associated with the user, (ii) chest movement of the user, (iii) a heart rate of the user, or (iv) any combination thereof” are a process, as drafted, covers performance of the limitation that can be performed by a human mind (including an observation, evaluation, judgment, opinion) under the broadest reasonable standard. For example, these limitations are nothing more than a medical professional analyzing a print out of generated sensor data to determine (i) a sleep disorder event associated with the user, (ii) chest movement of the user, (iii) a heart rate of the user, or (iv) any combination thereof. Regarding claim 30, the respiratory therapy system amounts to pre-solution and/or post-solution activity. The respiratory therapy system is a well-understood, routine, and conventional structure as evidenced by US 5535738 (col. 2 and lines 47-48-conventional treatments such as pressure support, CPAP or bi-level therapy), US 20160228661 (¶6-one known patient ventilator system), and US 4163450 (col. 1 and lines 39-40-conventional ventilator). Regarding claim 43, the control system and memory are recited at a high-level of generality and amount to nothing more than parts of a generic computer. Regarding claim 44, the control system is recited at a high-level of generality and amounts to nothing more than a part of a generic computer. Regarding claim 46, the non-transitory computer readable medium and computer are recited at a high-level of generality and amount to nothing more than parts of a generic computer. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 1, 3-4, 12, 16-17, 22, 43-44, and 46 are rejected under 35 U.S.C. 103 as being unpatentable over Gowda (US 20190053754 filed on 8/16/18) in view of Zavora (AU 2014262250 published on 12/4/14 as cited in the IDS). Regarding claim 1, Gowda teaches a method for determining a percentage likelihood that a user has an untreated sleep disorder, the method comprising: receiving, by a mobile device coupled to the user's chest (¶28-sensors may be placed on the chest of the user; ¶7-mobile device; ¶49), first physiological data associated with the user during a first time period (¶7-receive the set of features from the mobile device; ¶10-first sensor data; ¶86-sensor data is generated during a first period); analyzing, by the mobile device, the first physiological data (¶81-analyze the sensor data) to determine (i) a first respiration rate for the first time period (¶8-generate respiration data indicative of the user's respiration rate; ¶86-sensor data is generated during a first period), (ii) a first plurality of sample heart rate values (¶42-data representing the heart rate of the user of the wearable device 100 are calculated; ¶86-sensor data is generated during a first period), and (iii) first heart rate variability parameters for the first time period (¶42-data representing heart rate variability of the user of the wearable device 100 are calculated; ¶86-sensor data is generated during a first period); receiving, by the mobile device, second physiological data associated with the user during a second time period (¶7-receive the set of features from the mobile device; ¶10-second period, second sensor data); analyzing, by the mobile device, the second physiological data ¶81-analyze the sensor data) to determine (i) a second respiration rate for the second time period (¶8-generate respiration data indicative of the user's respiration rate; ¶10-sensor data is generated during a second period), (ii) a second plurality of sample heart rate values (¶42-data representing the heart rate of the user of the wearable device 100 are calculated; ¶10-sensor data is generated during a second period), and (iii) second heart rate variability parameters for the second time period (¶42-data representing heart rate variability of the user of the wearable device 100 are calculated; ¶10-sensor data is generated during a second period), the second respiration rate being less than the first respiration rate (¶56-classifies the temporal window as breathing disturbed based on detecting a pattern of low respiration (below a threshold level of respiration over a threshold amount of time)); determining, by the mobile device, the percentage likelihood that the user has the untreated sleep disorder based at least in part on the first heart rate variability parameters and the second heart rate variability parameters (¶71-the breathing disturbance score is one of normal (e.g., below 5%), mild (e.g., 5-10%), moderate (e.g., 10-20%), or severe (e.g., 20% or above); ¶87-determine the likelihood that the user is (or was) having a breathing disturbance during the given minute based on the similarity between the features extracted from the sensor streams and one or more predetermined features indicative of user having a breathing disturbance; ¶42-data representing the heart rate, heart rate variability, respiration rate, and/or oxygen saturation of the user of the wearable device 100 are calculated, and the resulting data is an additional input for classifying the temporal periods or generating the breathing disturbance score); receiving positional data associated with the user (¶47-sense position); wherein at least some of the (i) the first physiological data, (ii) the second physiological data, or (iii) both the first physiological data and the second physiological data are received from a heart rate sensor, a pulse sensor, an accelerometer, a pulse oximeter, an ECG device, or any combination thereof of the mobile device (¶7-photoplethysmographic (PPG) sensor; ¶39-the motion sensor(s) of the wearable device 100 (e.g., a multi-axis accelerometer 161, a gyroscope 162, or another motion sensor); ¶102-Sp02, electrical monitoring of heartbeats (ECG); ¶10). However, Gowda does not explicitly teach analyzing the received positional data to determine a body position of the user; and based, at least in part, on the determined body position of the user and the determined percentage likelihood that the user has the untreated sleep disorder, causing the user to change the body position. Zavora relates to the field of treating sleep disorders and more specifically to systems and methods using position therapy (PDT) to treat sleep disorders (¶1). Zavora further teaches the invention using the following steps: analyzing the received positional data to determine a body position of the user (¶61-the position detector 110 comprises one or more accelerometers that can be used to determine that the user's body position); and based, at least in part, on the determined body position of the user and the determined percentage likelihood that the user has the untreated sleep disorder (¶8-the device can be configured to limit the amount of time that the user spends sleeping in a supine position for users for whom it is not recommended to sleep in a supine position, such as OSA patients; ¶26-snoring can be an indicator of obstructed breathing, and the PTD 100 can be used in a therapy regime for OSA in which a user is discouraged from sleeping in a supine position. In an example, microphone 105 can be used to capture audio signals to assess snoring magnitude and frequency, which are likely to be position dependent; ¶67-for example, in an OSA patient, the patient's breathing can be interrupted resulting in the patient gasping for air. The data collected by the accelerometers can be analyzed to identify such events), causing the user to change the body position (¶8-the device can be configured to provide feedback to a user if the user is sleeping or is positioned in a target position to induce the user to change positions). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include analyzing the received positional data to determine a body position of the user; and based, at least in part, on the determined body position of the user and the determined percentage likelihood that the user has the untreated sleep disorder, causing the user to change the body position of Zavora in order to limit the amount of time that the user spends sleeping in a supine position for users for whom it is not recommended to sleep in a supine position, such as OSA patients (Zavora, ¶8). Regarding claim 3, the combination of Gowda and Zavora teaches the method of claim 1, wherein the first heart rate variability parameters for the first time period include a maximum heart rate for the first time period, a minimum heart rate for the first time period, a heart rate range defined by the maximum heart rate and the minimum heart rate for the first time period, an average heart rate for the first time period, a median heart rate for the first time period, a standard deviation of heart rates for the first time period, or any combination thereof (Gowda, ¶58-maximum change in heart rate over various timescales; and (ii) rolling median, average, or some other quartile of the distribution of heart rate derivative over various timescales; ¶86-a first period). Regarding claim 4, the combination of Gowda and Zavora teaches the method of claim 3, wherein the second heart rate variability parameters for the second time period include a maximum heart rate for the second time period, a minimum heart rate for the second time period, a heart rate range defined by the maximum heart rate and the minimum heart rate for the second time period, an average heart rate for the second time period, a median heart rate for the second time period, a standard deviation of heart rates for the second time period, or any combination thereof (Gowda, ¶58-maximum change in heart rate over various timescales; and (ii) rolling median, average, or some other quartile of the distribution of heart rate derivative over various timescales; ¶10-second period). Regarding claim 12, the combination of Gowda and Zavora teaches the method of claim 1, wherein the untreated sleep disorder includes untreated obstructive sleep apnea (Zavora, ¶1-treating sleep disorders; ¶8-OSA patients). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the untreated sleep disorder includes untreated obstructive sleep apnea of Zavora because it is not recommended to sleep in a supine position for OSA patients (Zavora, ¶20). Regarding claim 16, the combination of Gowda and Zavora teaches the method of claim 1, further comprising displaying an indication of the determined percentage likelihood that the user has the untreated sleep disorder (Gowda, ¶7-the mobile device to receive the determined score(s) from the server and cause the score(s) to be displayed on a display screen of the mobile device; ¶89-at block 520 , the system outputs the breathing disturbance score for presentation to the user; ¶71-the breathing disturbance score is one of normal (e.g., below 5%), mild (e.g., 5-10%), moderate (e.g., 10-20%), or severe (e.g., 20% or above). In another example, breathing disturbance score is one of normal (e.g., below 5%) or not normal (e.g., 5% or above)). Regarding claim 17, the combination of Gowda and Zavora teaches the method of claim 16, further comprising in response to the determined percentage likelihood that the user has the untreated sleep disorder exceeding 50%, displaying the indication that the user is likely to have the untreated sleep disorder (Gowda, ¶7-the mobile device to receive the determined score(s) from the server and cause the score(s) to be displayed on a display screen of the mobile device; ¶89-at block 520 , the system outputs the breathing disturbance score for presentation to the user; ¶71-the breathing disturbance score is one of normal (e.g., below 5%), mild (e.g., 5-10%), moderate (e.g., 10-20%), or severe (e.g., 20% or above). In another example, breathing disturbance score is one of normal (e.g., below 5%) or not normal (e.g., 5% or above); ¶72-a sleep apnea severity score (e.g., normal for AHI below 5, mild for AHI of 5 or greater and below 15, moderate for AHI of 15 or greater and below 30, and severe for AHI of 30 or above). The system may also output a graph illustrating the trend in the breathing disturbance scores or metrics of the user over time (e.g., daily, weekly, monthly, and/or yearly)). Regarding claim 22, the combination of Gowda and Zavora teaches the method of claim 1, wherein the causing the user to change the body position includes causing a sound or a vibration to be communicated to the user (Zavora, ¶26-provide haptic and/or audiovisual feedback to the user to induce the user to shift to a different sleep position; ¶9-generate a control signal to cause the haptic feedback device to provide tactile feedback to the user to induce the user to change to a different, non-target sleep position if the user of the device is in a target sleep position). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the causing the user to change the body position includes causing a sound or a vibration to be communicated to the user of Zavora in order to limit the amount of time that the user spends sleeping in a supine position for users for whom it is not recommended to sleep in a supine position, such as OSA patients (Zavora, ¶8). Regarding claim 43, the combination of Gowda and Zavora teaches a system comprising: a control system including one or more processors (Gowda, ¶24-processor 120 (which may be a set of processors)); and a memory having stored thereon machine readable instructions (Gowda, ¶25-the memory 130 may store instructions); wherein the control system is coupled to the memory (Gowda, ¶25-the memory 130 may store instructions for causing the processor 120 to perform certain actions), and the method of claim 1 is implemented when the machine executable instructions in the memory are executed by at least one of the one or more processors of the control system (Gowda, ¶31-a device may store instructions for the software in a suitable, non-transitory computer-readable medium and execute the instructions in hardware using one or more processors to perform the techniques of this disclosure). Regarding claim 44, the combination of Gowda and Zavora teaches a system for determining a percentage likelihood that a user has an untreated sleep disorder, the system including a control system configured to implement the method of claim 1 (Gowda, ¶31-a device may store instructions for the software in a suitable, non-transitory computer-readable medium and execute the instructions in hardware using one or more processors to perform the techniques of this disclosure). Regarding claim 46, the combination of Gowda and Zavora teaches a non-transitory computer readable medium comprising instructions which, when executed by a computer, cause the computer to carry out the method of claim 1 (Gowda, ¶11-non-transitory physical computer storage storing instructions. The instructions may, when executed by one or more processors, configure the one or more processors; ¶31-a device may store instructions for the software in a suitable, non-transitory computer-readable medium and execute the instructions in hardware using one or more processors to perform the techniques of this disclosure). Claim 2 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 1 above, and further in view of Insler (US 20170172522 filed on 12/22/16 as cited in the IDS). Regarding claim 2, the combination of Gowda and Zavora teaches the method of claim 1. However, the combination of Gowda and Zavora does not teach wherein the second respiration rate is at least 10% less, at least 20% less, at least 30% less, at least 40% less, at least 50% less, at least 60% less, or at least 70% less than the first respiration rate. Insler teaches wherein the second respiration rate is at least 10% less, at least 20% less, at least 30% less, at least 40% less, at least 50% less, at least 60% less, or at least 70% less than the first respiration rate (claim 7-respiratory rate… 10-15 percent decrease below a baseline established for the individual). Insler relates to transmitting, if the alarm was interrupted, information that the individual may have sleep apnea (¶20). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the second respiration rate is at least 10% less, at least 20% less, at least 30% less, at least 40% less, at least 50% less, at least 60% less, or at least 70% less than the first respiration rate of Insler because reduced respiratory rate is consistent with conditions such as sleep apnea (Insler, ¶21). Claim 5 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 1 above, and further in view of Christopherson (US 20170128002 filed on 8/17/1 as cited in the IDS). Regarding claim 5, the combination of Gowda and Zavora teaches the method of claim 4. However, the combination of Gowda and Zavora does not explicitly teach in response to the heart rate range for the second time period being no greater than the heart rate range for the first time period, determining that the percentage likelihood that the user has the untreated sleep disorder is greater than 40%, 50%, 60%, 70%, 80%, or 90%. Christopherson teaches in response to the heart rate range for the second time period being no greater than the heart rate range for the first time period, determining that the percentage likelihood that the user has the untreated sleep disorder is greater than 40%, 50%, 60%, 70%, 80%, or 90% (¶82-sleep disordered breathing behavior is confirmed via detection of a decreasing heart rate; ¶135-heart rate is known to decrease at the onset of an obstructive apnea; ¶140-the number of apneas, the duration of an apnea, and intensity of apneas (as well as other physiologic data) are combined into a severity score; ¶137; ¶145). Christopherson relates to an implantable stimulation system for stimulating and monitoring soft tissue in a patient, and more particularly, the present disclosure relates to a method of automatically initiating and adjusting therapeutic treatment of sleep apneas (¶2). Christopherson additionally relates to being adapted to treat sleep disordered breathing behavior, such as obstructive sleep apnea (¶28). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include in response to the heart rate range for the second time period being no greater than the heart rate range for the first time period, determining that the percentage likelihood that the user has the untreated sleep disorder is greater than 40%, 50%, 60%, 70%, 80%, or 90% of Christopherson in order to treat sleep disordered breathing behavior, such as obstructive sleep apnea (Christopherson, ¶28). Claims 6 and 10 are rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 1 above, and further in view of Pu (US 20100204586 filed on 2/12/09 as cited in the IDS). Regarding claim 6, the combination of Gowda and Zavora teaches the method of claim 4. However, the combination of Gowda and Zavora does not explicitly teach based at least in part on the heart rate range for the second time period not exceeding a threshold value, determining that the user is likely to have the untreated sleep disorder. Pu teaches based at least in part on the heart rate range for the second time period not exceeding a threshold value, determining that the user is likely to have the untreated sleep disorder (¶70-heart rate cyclically falls below a threshold baseline heart rate 1205 during an interval 1210 in which both bradycardia and cyclic variation in heart rate are present; ¶75- collective scoring of tachycardia indices, bradycardia indices, and variation in heart rate indicates that a sleep disorder is present). Pu relates to detecting the existence of a sleep disorder in an individual using heart activity (¶1). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include based at least in part on the heart rate range for the second time period not exceeding a threshold value, determining that the user is likely to have the untreated sleep disorder of Pu in order to report an obstructive sleep apnea event in response to the determination that sleep apnea is indicated (Pu, ¶10). Regarding claim 10, the combination of Gowda, Zavora, and Pu teaches the method of claim 6, further comprising: receiving a first time stamp associated with the first time period and a second time stamp associated with the second time period (Gowda, ¶9-respective temporal window of a plurality of temporal windows within the sleep period); and based at least in part on the first time stamp and the second time stamp, determining a severity of the untreated sleep disorder (Gowda, ¶70- determine the severity of breathing disturbance for a given sleep period). Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora, and further in view of Pu as applied to claim 6 above, and further in view of Shinar (US 20130281866 filed on 6/19/13 as cited in the IDS). Regarding claim 7, the combination of Gowda, Zavora, and Pu teaches the method of claim 6. However, the combination of Gowda, Zavora, and Pu does not explicitly teach wherein the threshold value is 6 bpm, 7 bpm, 8 bpm, 9 bpm, 10 bpm, 11 bpm, 12 bpm, 13 bpm, 14 bpm, 15 bpm, 16 bpm, 17 bpm, 18 bpm, 19 bpm, 20 bpm, 21 bpm, or 22 bpm. Shinar teaches wherein the threshold value is 6 bpm, 7 bpm, 8 bpm, 9 bpm, 10 bpm, 11 bpm, 12 bpm, 13 bpm, 14 bpm, 15 bpm, 16 bpm, 17 bpm, 18 bpm, 19 bpm, 20 bpm, 21 bpm, or 22 bpm (¶161-a threshold amount of more than 15 beats per minute; ¶163-a heart rate threshold of 22 beats per minute). Shinar relates generally to predicting and monitoring physiological conditions. Specifically, some applications relate to methods and apparatus for monitoring a subject by monitoring the subject's respiration rate and/or the subject's heart rate (¶5). Shinar additionally relates to predicting an onset of apnea (Abstract; ¶197). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the threshold value is 6 bpm, 7 bpm, 8 bpm, 9 bpm, 10 bpm, 11 bpm, 12 bpm, 13 bpm, 14 bpm, 15 bpm, 16 bpm, 17 bpm, 18 bpm, 19 bpm, 20 bpm, 21 bpm, or 22 bpm of Shinar in order to predict an onset of apnea (Shinar, Abstract, ¶197). Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 1 above, and further in view of Shinar. Regarding claim 8, the combination of Gowda and Zavora teaches the method of claim 1. However, the combination of Gowda and Zavora does not explicitly teach wherein the determining the percentage likelihood that the user has the untreated sleep disorder includes comparing the first heart rate variability parameters to the second heart rate variability parameters. Shinar wherein the determining the percentage likelihood that the user has the untreated sleep disorder includes comparing the first heart rate variability parameters to the second heart rate variability parameters (¶157-(i.e., thresholds for the difference between median or maximum heart rate and those of the previous day) for determining the likelihood of a subject undergoing (a) any adverse clinical event). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the determining the percentage likelihood that the user has the untreated sleep disorder includes comparing the first heart rate variability parameters to the second heart rate variability parameters of Shinar in order to predict an onset of apnea (Shinar, Abstract, ¶197). Claim 9 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora, and further in view of Pu as applied to claim 6 above, and further in view of Fujita (WO 2016093347 filed on 12/11/15 as cited in the IDS). Regarding claim 9, the combination of Gowda, Zavora, and Pu teaches the method of claim 6. However, the combination of Gowda, Zavora, and Pu does not explicitly teach receiving a first time stamp associated with the first time period and a second time stamp associated with the second time period; and based at least in part on the first time stamp and the second time stamp, determining the percentage likelihood that the user has the untreated sleep disorder. Fujita teaches receiving a first time stamp associated with the first time period and a second time stamp associated with the second time period; and based at least in part on the first time stamp and the second time stamp, determining the percentage likelihood that the user has the untreated sleep disorder (Abstract, page 12-calculates the number of appearances thereof per unit time, and estimates the risk of disease related to sleep from the relationship between the calculated number of appearances; page 1, last ¶). Fujita relates to a biological condition analyzing apparatus and a computer program for analyzing the state of a person from a biological signal, and more particularly to a biological state analyzing apparatus and computer program for analyzing the state of a person (page 1, ¶1). Fujita additionally relates to estimating a sleep-related disease risk including sleep apnea syndrome (page 1, 3rd to last ¶). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include receiving a first time stamp associated with the first time period and a second time stamp associated with the second time period; and based at least in part on the first time stamp and the second time stamp, determining the percentage likelihood that the user has the untreated sleep disorder of Fujita in order to estimate a risk of sleep apnea syndrome (Fujita, page 1, 3rd to last ¶). Claim 18 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 1 above, and further in view of Somers (US 20100323379 filed on 9/25/08 as cited in the IDS). Regarding claim 18, the combination of Gowda and Zavora teaches the method of claim 1. However, the combination of Gowda and Zavora does not explicitly teach wherein (i) the first time period, (ii) the second time period, or (iii) both the first time period and the second time period are within 30 minutes, an hour, two hours, or three hours of the user waking up. Somers relates to methods and materials involved in diagnosing sleep apnea (e.g., obstructive or central sleep apnea) and assessing the effectiveness of a treatment for sleep apnea (¶7). Somers teaches wherein (i) the first time period, (ii) the second time period, or (iii) both the first time period and the second time period are within 30 minutes, an hour, two hours, or three hours of the user waking up (¶40-measurements can be obtained before and immediately after sleep, and if necessary, several hours after waking). Somers therefore envisions a time period after the user wakes up. While Somers is not specific on the amount of hours after waking, the Examiner contends it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention for the time period to be two or three hours, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum size involves only routine skill in the art. In re Aller, 105 USPQ 233. Claims 11, 19-20, and 24-30 are rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 1 above, and further in view of Shouldice (WO 2017032873 filed on 8/26/16 as cited in the IDS). Regarding claim 11, the combination of Gowda and Zavora teaches the method of claim 1. However, the combination of Gowda and Zavora does not explicitly teach receiving additional physiological data associated with the user during an additional time period; analyzing the additional physiological data to determine (i) an additional respiration rate for the additional time period, (ii) an additional plurality of sample heart rate values, and (iii) additional heart rate variability parameters for the additional time period, the additional respiration rate being less than the first respiration rate; and determining a severity of the untreated sleep disorder based at least in part on the first heart rate variability parameters, the second heart rate variability parameters, and the additional heart rate variability parameters. Shouldice teaches receiving additional physiological data associated with the user during an additional time period; analyzing the additional physiological data to determine (i) an additional respiration rate for the additional time period, (ii) an additional plurality of sample heart rate values, and (iii) additional heart rate variability parameters for the additional time period, the additional respiration rate being less than the first respiration rate; and determining a severity of the untreated sleep disorder based at least in part on the first heart rate variability parameters, the second heart rate variability parameters, and the additional heart rate variability parameters (¶50-detect a change in the parameter over a period of time; ¶49-at least one of the one or more physiological parameters or the additional physiological parameter may be one of breathing rate, heart rate; ¶50-heart rate variability (HRV); ¶230-a respiration rate of 27 breaths per minute during a respiratory attack, reducing the respiration rate to 20 breaths per minute in the hour after treatment for an event, and then further reducing to baseline of 17 breaths per minute); ¶103-monitor and/or detect user specific patterns related to onset and severity of chronic respiratory diseases). Shouldice relates systems and methods for monitoring a patient suffering from a chronic disease, such as a chronic respiratory and/or cardiac disease, including, for example, asthma, chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF), based on multiple sources of information, and managing the patient's condition in the context of their overall lifestyle (¶2). Shouldice additionally relates to treating Obstructive Sleep Apnea (OSA) (¶35). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include receiving additional physiological data associated with the user during an additional time period; analyzing the additional physiological data to determine (i) an additional respiration rate for the additional time period, (ii) an additional plurality of sample heart rate values, and (iii) additional heart rate variability parameters for the additional time period, the additional respiration rate being less than the first respiration rate; and determining a severity of the untreated sleep disorder based at least in part on the first heart rate variability parameters, the second heart rate variability parameters, and the additional heart rate variability parameters of Shouldice in order to treat Obstructive Sleep Apnea (OSA) (Shouldice, ¶35). Regarding claim 19, the combination of Gowda and Zavora teaches the method of claim 1. However, the combination of Gowda and Zavora does not explicitly teach prior to receiving the second physiological data associated with the user during the second time period, causing the user to breathe slower than the first respiration rate. Shouldice teaches prior to receiving the second physiological data associated with the user during the second time period, causing the user to breathe slower than the first respiration rate (¶230-a respiration rate of 27 breaths per minute during a respiratory attack, reducing the respiration rate to 20 breaths per minute in the hour after treatment for an event, and then further reducing to baseline of 17 breaths per minute). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include prior to receiving the second physiological data associated with the user during the second time period, causing the user to breathe slower than the first respiration rate of Shouldice in order to treat Obstructive Sleep Apnea (OSA) (Shouldice, ¶35). Regarding claim 20, the combination of Gowda, Zavora, and Shouldice teaches the method of claim 19, wherein the causing the user to breathe slower than the first respiration rate includes instructing the user to stay still and relax (Shouldice, ¶164-a person in a pre-exacerbation phase of the condition may be instructed to undertake relaxing breathing exercises such as meditation; ¶230). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the causing the user to breathe slower than the first respiration rate includes instructing the user to stay still and relax of Shouldice in order to treat Obstructive Sleep Apnea (OSA) (Shouldice, ¶35). Regarding claim 24, the combination of Gowda and Zavora teaches the method of claim 1. However, the combination of Gowda and Zavora does not explicitly teach based at least in part on the determined percentage likelihood that the user has the untreated sleep disorder, instructing the user to wear a treatment device. Shouldice teaches based at least in part on the determined percentage likelihood that the user has the untreated sleep disorder, instructing the user to wear a treatment device (¶169-estimate a likelihood that a specific person will suffer progression (e.g., worsening) of a specific disease; ¶54-communicating data concerning application of a treatment by using a treatment device adapted for treating the chronic condition of the user, instruct the user to effect a treatment, or to undertake an action; ¶68-the physiological monitor may be adapted to be wearable by the user). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include based at least in part on the determined percentage likelihood that the user has the untreated sleep disorder, instructing the user to wear a treatment device of Shouldice in order to treat Obstructive Sleep Apnea (OSA) (Shouldice, ¶35). Regarding claim 25, the combination of Gowda, Zavora, and Shouldice teaches the method of claim 24, wherein the treatment device is configured to (i) generate sensor data, (ii) cause a sound or a vibration to be communicated to the user, or (iii) both (i) and (ii) (Shouldice, ¶46-wearable by the user and may be operative to generate a first physiological signal associated with a first physiological parameter of the user, the method may include receiving one or more generated physiological signals; ¶129- the device may provide or trigger an alert to the user 202 (audio, visual or vibration)). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the treatment device is configured to (i) generate sensor data, (ii) cause a sound or a vibration to be communicated to the user, or (iii) both (i) and (ii) of Shouldice in order to treat Obstructive Sleep Apnea (OSA) (Shouldice, ¶35). Regarding claim 26, the combination of Gowda, Zavora, and Shouldice teaches the method of claim 25, wherein the sensor data includes positional data associated with the user (Gowda, ¶47-sense position). Regarding claim 27, the combination of Gowda, Zavora, and Shouldice teaches the method of claim 25, wherein the sensor data is generated using a motion sensor (Gowda, ¶10-one or more motion sensors). Regarding claim 28, the combination of Gowda, Zavora, and Shouldice teaches the method of claim 27, wherein the motion sensor includes an accelerometer, a gyroscope, a magnetometer, or any combination thereof (Gowda, ¶25-motion sensors or inertial sensors (e.g., accelerometer, gyroscope, digital compass, etc.); ¶28-the wearable device 100 includes an accelerometer 161 (e.g., a multi-axis accelerometer), a gyroscope 162, a magnetometer 163). Regarding claim 29, the combination of Gowda, Zavora, and Shouldice teaches the method of claim 25, further comprising analyzing the generated sensor data to determine (i) a sleep disorder event associated with the user, (ii) chest movement of the user, (iii) a heart rate of the user, or (iv) any combination thereof (Gowda, ¶71-the breathing disturbance score is one of normal (e.g., below 5%), mild (e.g., 5-10%), moderate (e.g., 10-20%), or severe (e.g., 20% or above); ¶87-determine the likelihood that the user is (or was) having a breathing disturbance during the given minute based on the similarity between the features extracted from the sensor streams and one or more predetermined features indicative of user having a breathing disturbance; ¶42-data representing the heart rate, heart rate variability, respiration rate, and/or oxygen saturation of the user of the wearable device 100 are calculated, and the resulting data is an additional input for classifying the temporal periods or generating the breathing disturbance score). Regarding claim 30, the combination of Gowda, Zavora, and Shouldice teaches the method of claim 24, wherein the treatment device is a respiratory therapy system (Gowda, ¶74-CPAP therapy). Claim 23 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 22 above, and further in view of Wren (WO 2019122413 filed on 12/21/18 as cited in the IDS). Regarding claim 23, the combination of Gowda and Zavora teaches the method of claim 22. However, the combination of Gowda and Zavora does not explicitly teach wherein a level of the sound or the vibration to be communicated to the user is (i) proportional to a determined severity of the untreated sleep disorder. Wren teaches wherein a level of the sound or the vibration to be communicated to the user is (i) proportional to a determined severity of the untreated sleep disorder (¶12-the control signal to change a setting of the interactive audio device may include a change in volume based on a detection of user distance from the interactive audio device, user’s state or user’s location; ¶180-users with various health conditions, including respiratory conditions such as sleep apnea, COPD, cardiac issues and so forth). Wren relates to detecting bio-motion associated with living subjects with audio equipment. More particularly, the present technology relates to using acoustic sensing with audio equipment to detect physiological characteristics such as physiological movement such as breathing movement, cardiac movement and/or other less cyclical body movement of a living subject (¶2). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein a level of the sound or the vibration to be communicated to the user is (i) proportional to a determined severity of the untreated sleep disorder of Wren in order for waking the user up (Wren, ¶220). Claim 31 is rejected under 35 U.S.C. 103 as being unpatentable over Gowda in view of Zavora as applied to claim 1 above, and further in view of Shouldice and Bennett-Guerrero (US 9028407 filed on 12/13/13 as cited in the IDS), hereinafter referred to as Bennett. Regarding claim 31, the combination of Gowda and Zavora teaches the method of claim 1. However, the combination of Gowda and Zavora does not teach wherein the first respiration rate is more than six breaths per minute, and the second respiration rate is six or fewer breaths per minute. Shouldice teaches wherein the first respiration rate is more than six breaths per minute (¶333-12 breaths per minute; ¶230). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda wherein the first respiration rate is more than six breaths per minute of Shouldice in order to treat Obstructive Sleep Apnea (OSA) (Shouldice, ¶35). While Shouldice teaches a respiration rate (¶333), the combination does not teach wherein the second respiration rate is six or fewer breaths per minute. Bennett teaches the second respiration rate is six or fewer breaths per minute (col. 29 and lines 54-55-the respiratory rate is less than a default value, e.g., 6 breaths per minute). Bennett relates to 1) varying the frequency of chest incline measurements, such as based on changing patient conditions; 2) certain applications of monitoring patient inclines over time, such as addressing seizures, SIDS, sleep related conditions, etc., and generating various types of relevant reports, e.g., indicating a percentage of time in which the patient chest incline angle is less than a certain angle (e.g., 30 degrees) over a certain period (e.g., over 24 hours); and 3) using the same accelerometer that measures patient incline to also measure other patient conditions, i.e., respiration, heart rate, gastrointestinal function, and related applications (col. 3 and lines 47-57). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the invention of Gowda to include wherein the first respiration rate is more than six breaths per minute, and the second respiration rate is six or fewer breaths per minute of Bennett in order to diagnose sleep-related conditions, including but limited to sleep apnea (Bennett, col. 12 and lines 17-18). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 20070073181: relates generally to respiration detection and monitoring and, more particularly, to use of respiration rate variability and a footprint of same to detect, monitor, predict, and/or treat a patient condition (¶2). Any inquiry concerning this communication or earlier communications from the examiner should be directed to LAURA HODGE whose telephone number is (571)272-7101. The examiner can normally be reached M-F: 8:00 am-5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, BENJAMIN KLEIN can be reached at (571) 270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LAURA HODGE/Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

May 01, 2025
Application Filed
Nov 05, 2026
Non-Final Rejection mailed — §101, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12796940
METHODS AND SYSTEMS FOR DETERMINING A PHYSIOLOGICAL OR BIOLOGICAL STATE OR CONDITION OF A SUBJECT
5y 9m to grant Granted Nov 17, 2026
Patent 12788294
Fatigue Evaluation Based On Sleep Quality And Physical Activity
3y 11m to grant Granted Nov 10, 2026
Patent 12778429
METHODS, SYSTEMS AND DEVICES FOR UTILIZING MULTIPLE AF DISCRIMINATORS
5y 2m to grant Granted Nov 03, 2026
Patent 12773147
MULTIPARAMETER LEAD SET AND METHODS OF USE THEREOF
5y 0m to grant Granted Oct 27, 2026
Patent 12751855
SLEEP MONITORING DEVICE
5y 4m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
49%
Grant Probability
89%
With Interview (+40.1%)
3y 7m (~2y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 126 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month